The Biology
How Peptides Restore Hair
Hair loss is not one problem. It is several biological failures happening simultaneously. Peptides are effective because each one addresses a specific mechanism — and they can be combined to cover all of them at once.
The most common mistake is treating hair loss as a DHT problem only. DHT is the initiating signal. But by the time visible thinning occurs, downstream damage — compromised vasculature, perifollicular fibrosis, depleted stem cell activity — is already present. Addressing only DHT at that point is treating a symptom, not the disease state.
Wnt/β-Catenin Signaling
The master switch for follicle activation
The Wnt pathway is the embryonic program that builds hair follicles. In adults, it orchestrates each growth cycle. When Wnt signaling is suppressed — by DHT-induced CXXC5 upregulation, by TGF-β, by cellular senescence — follicles miniaturize and eventually cease cycling. GHK-Cu and PTD-DBM both activate this pathway through different upstream mechanisms.
Angiogenesis
Rebuilding blood supply to starved follicles
A healthy anagen follicle requires a dense capillary network for nutrient and oxygen delivery. In androgenetic alopecia, this vasculature regresses. Laser Doppler studies confirm measurably lower blood flow velocity in balding scalp regions. BPC-157 drives VEGF upregulation and endothelial tube formation, rebuilding this infrastructure. GHK-Cu provides additional VEGF stimulus.
Anti-Fibrotic Remodeling
Dissolving the collagen cage around follicles
Perifollicular fibrosis — excess collagen deposition around the follicle sheath — is a consistent histological finding in AGA. It physically constricts follicles and may reduce diameter by 30–40% before visible thinning. DHT-driven TGF-β1 is the primary driver. TB-500 upregulates MMP-2 to degrade excess collagen and suppresses NF-κB to reduce TGF-β1 production.
Stem Cell Activation
Recruiting the follicle's own regenerative cells
Hair follicle stem cells (HFSCs) reside in the bulge region and initiate each new anagen cycle. In chronic AGA, HFSC quiescence becomes pathologically prolonged — the cells are present but not recruited. GHK-Cu provides the Wnt signals that activate HFSCs. PTD-DBM removes the inhibitory brake (CXXC5) that keeps them dormant.
Growth Factor Stimulation
Direct anabolic signals to follicle cells
Dermal papilla cells are the command center of the hair follicle — they signal to surrounding cells to begin and maintain active growth. In AGA, DHT progressively impairs dermal papilla function and reduces their secretion of IGF-1, a key proliferative signal for follicle keratinocytes. IGF-1 LR3 bypasses this suppression by directly activating IGF-1R on follicle cells.
TGF-β Neutralization
Removing the brake on follicle cycling
TGF-β1 and its family members (activin, myostatin, BMP-4) are primary suppressors of hair follicle activity. They drive catagen entry and inhibit dermal papilla survival. Follistatin 344 is a high-affinity binding protein for these molecules — it acts as a molecular sponge, sequestering the inhibitory signals and allowing the Wnt cascade and growth factors to operate without suppression.
The Hair Follicle Cycle
Anagen
2–7 years
Active growth phase. The follicle is metabolically active, producing a growing hair shaft. Peptides aim to extend this phase.
Catagen
2–3 weeks
Regression phase. The follicle shrinks, the hair stops growing, and the lower portion of the follicle is destroyed and rebuilt.
Telogen
3–4 months
Resting phase. The hair remains but the follicle is inactive. Shedding occurs at the end when a new anagen hair pushes the old one out.